Back to Search Start Over

Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations

Authors :
Franck Sturtz
Jean-Michel Vallat
Robert A. Ouvrier
Corinne Magdelaine
Danqing Zhu
S. Grew
Monique M. Ryan
Garth A. Nicholson
Service de Biochimie et Génétique Moléculaire [CHU Limoges]
CHU Limoges
Biomolécules Thérapies anti-tumorales (EA4021)
Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)
Service de Neurologie [CHU Limoges]
Source :
Neurology, Neurology, American Academy of Neurology, 2008, 70 (19), pp.1678-81. ⟨10.1212/01.wnl.0000311275.89032.22⟩
Publication Year :
2008
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2008.

Abstract

Objective: Severe early-onset axonal neuropathy (SEOAN) is a heterogeneous phenotype first delineated by Ouvrier et al., characterized by progressive axonal degeneration with gait problems often progressing to wheelchair requirement and later respiratory involvement. Most cases are sporadic single cases. Some have heterozygous mitofusin 2 (MFN2) mutations, many of which are de novo dominant mutations. The aim of this study was to investigate the mode of inheritance in three individuals with severe early-onset axonal neuropathy and homozygous or compound heterozygous MFN2 mutations.Methods: The clinical and molecular findings in the parents of three individuals with SEOAN with homozygous or compound heterozygous MFN2 mutations were examined.Results: All parents were asymptomatic or mildly symptomatic with some signs of peripheral neuropathy indicating a minimal phenotype. Two had hearing problems. All parents carried the relevant single base (heterozygous) MFN2 variations.Conclusion: Severe early-onset axonal neuropathy due to MFN2 mutations can present as an apparently recessively inherited neuropathy but the minimal phenotype in the parents suggests a semi-dominant mechanism.

Subjects

Subjects :
Male
Pathology
Wallerian degeneration
[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology
DNA Mutational Analysis
Inheritance Patterns
MESH: Genetic Markers
Compound heterozygosity
medicine.disease_cause
GTP Phosphohydrolases
MESH: Genotype
0302 clinical medicine
Genotype
MESH: DNA Mutational Analysis
Age of Onset
MESH: Heterozygote
Genes, Dominant
Genetics
0303 health sciences
Mutation
MESH: Genetic Testing
Homozygote
MESH: Genetic Predisposition to Disease
MESH: Mitochondrial Proteins
Peripheral Nervous System Diseases
Phenotype
3. Good health
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Female
MESH: Membrane Proteins
MESH: Peripheral Nervous System Diseases
MESH: Homozygote
Adult
Genetic Markers
MESH: Axons
Heterozygote
medicine.medical_specialty
MESH: Mutation
MESH: Age of Onset
Hearing Loss, Sensorineural
Biology
Mitochondrial Proteins
03 medical and health sciences
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
medicine
Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Genetic Predisposition to Disease
Genetic Testing
Peripheral Nerves
030304 developmental biology
[SDV.GEN]Life Sciences [q-bio]/Genetics
MESH: Humans
Membrane Proteins
MESH: Adult
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
Heterozygote advantage
MESH: Peripheral Nerves
medicine.disease
MESH: Male
Axons
Peripheral neuropathy
MESH: Hearing Loss, Sensorineural
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
nervous system
Neurology (clinical)
MESH: Inheritance Patterns
Age of onset
MESH: Wallerian Degeneration
MESH: Genes, Dominant
Wallerian Degeneration
MESH: Female
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
030217 neurology & neurosurgery

Details

ISSN :
1526632X and 00283878
Volume :
70
Database :
OpenAIRE
Journal :
Neurology
Accession number :
edsair.doi.dedup.....1dfecb62c3f66e961dda6accac29d5f0
Full Text :
https://doi.org/10.1212/01.wnl.0000311275.89032.22